91视频

?
?
?
?
Home Tags Posts tagged with "YS Biopharma"

Tag: YS Biopharma

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Correspondents

AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners
SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
Follow 91视频
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 91视频. All rights reserved.

Follow us on LinkedIn